Tirzepatide for treating type 2 diabetes ID3938 In development [GID-TA10835] Expected publication date: TBC Type Technology appraisal guidance Status In development
Therapeutics for people with COVID-19 [ID4038] In development [GID-TA10936] Expected publication date: TBC Type Technology appraisal guidance Status In development